Woman's World on MSN54 分钟
Dealing with a Blocked Nostril? Here's How to Clear It Fast!
Have you ever been frustrated by one side of your nose feeling completely blocked while the other is clear? As annoying as it ...
AstraZeneca announces WAYPOINT trial met both co-primary endpoints
Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...
FiercePharma6 小时
AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study
A phase 3 study has shown that when compared with placebo, Tezspire provided a statistically significant and clinically ...
EuropaWire6 小时
Tezspire Shows Promise in Reducing Nasal Polyp Symptoms in Phase III Trial for Chronic ...
(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...
Amgen, AstraZeneca announce top-line results from WAYPOINT trial
Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...
Yahoo Finance9 小时
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The therapy met the co-primary endpoint of the WAYPOINT ...
Yahoo Finance9 小时
TEZSPIRE met both co-primary endpoints in the Phase III WAYPOINT trial in patients with ...
November 08, 2024--(BUSINESS WIRE)--Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP ... significant and clinically ...
Battling Sinus Woes? Here’s How Seasonal Allergies Can Wreak Havoc and What You Can Do ...
Expert says, that by recognising the connection between seasonal changes, allergies, and sinus health, individuals can take ...
Amgen, AstraZeneca post Phase 3 win for nasal polyps therapy
Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...
AstraZeneca touts positive results from nasal polyp treatment study
AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a disorder characterised by ...